Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiming Granule for diabetic microangiopathy with diabetic retinopathy and diabetic nephropathy
ChiCTR-TRC-12002953Phase 4Completed
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Jan 2011
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qiming granule in diabetic retinopathy (DR), diabetic glomerulosclerosis and diabetic microangiopathy (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Incidence of proliferative diabetic retinopathy and Microalbuminuria. Started Jan 2011; status: completed.
02
Drugs
qiming granule
03
Conditions
diabetic retinopathy (DR)diabetic glomerulosclerosisdiabetic microangiopathy
Beyond the preview
Go deeper on ChiCTR-TRC-12002953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002953.